Trials / Sponsors / Rahul Aggarwal
Rahul Aggarwal
Academic / Other · 13 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Imaging of Solid Tumors Using 18F-TRX Solid Tumor, Solid Carcinoma, Castration-Resistant Prostate Carcinoma | Phase 1 | 2025-07-03 |
| Recruiting | 64Cu-GRIP B in Patients With Advanced Malignancies Prostate Cancer, Renal Cancer, Urethral Cancer | Phase 1 / Phase 2 | 2023-05-25 |
| Terminated | Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer Small Cell Neuroendocrine Carcinoma, Prostate Cancer, Small Cell Carcinoma | Phase 2 | 2022-03-16 |
| Active Not Recruiting | FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer Metastatic Castration-resistant Prostate Cancer, Prostate Cancer | Phase 1 / Phase 2 | 2022-01-19 |
| Terminated | 11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor Expression Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 | Phase 1 | 2021-08-10 |
| Active Not Recruiting | ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Metastatic Prostate Small Cell Carcinoma | Phase 2 | 2021-01-26 |
| Recruiting | Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors Clear Cell Renal Cell Carcinoma, Locally Advanced Pancreatic Cancer, Locally Advanced Malignant Solid Neoplasm | Phase 2 | 2019-01-17 |
| Completed | Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies Stage III Cutaneous Melanoma, Stage IV Cutaneous Melanoma, Locally Advanced Melanoma | Phase 1 | 2018-08-20 |
| Terminated | Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (HP) (13C) in Castration-Resistant Prostate Cance Prostate Cancer | Phase 1 | 2016-11-08 |
| Terminated | Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor Malignancies Prostate Cancer | Phase 1 / Phase 2 | 2016-10-20 |
| Completed | LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC Prostate Cancer | Phase 1 / Phase 2 | 2015-11-20 |
| Completed | Gallium-68 Citrate PET Used in Prostate Cancer Prostatic Neoplasms | EARLY_Phase 1 | 2015-05-28 |
| Completed | Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer Metastatic Castration-resistant Prostate Cancer | Phase 1 | 2012-06-01 |